High-dose methotrexate in the treatment of adult acute lymphoblastic leukemia

Annals of Hematology

Volumn 72, Issue 4, 1996, Pages 194-201

  Gokbuget N ^a   Hoelzer, D ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Adult; ALL; Chemotherapy; High dose; Methotrexate

Indexed keywords

AMINOPHYLLINE; ANTINEOPLASTIC AGENT; ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; ETOPOSIDE; FOLINIC ACID; HYDROCORTISONE; IFOSFAMIDE; MERCAPTOPURINE; METHOTREXATE; MITOXANTRONE; PREDNISONE; STEROID; TENIPOSIDE; TIOGUANINE; VINCRISTINE; VINDESINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANAPHYLAXIS; ANTINEOPLASTIC ACTIVITY; B CELL LEUKEMIA; BONE MARROW RESCUE; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CHILDHOOD LEUKEMIA; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG CYTOTOXICITY; DRUG EFFICACY; ERYTHEMA; HEADACHE; HUMAN; INTRATHECAL DRUG ADMINISTRATION; LEUKEMIC MENINGITIS; LIVER DYSFUNCTION; MUCOSA INFLAMMATION; NEPHROTOXICITY; NEUROTOXICITY; PLEURISY; PRIORITY JOURNAL; REVIEW; SEIZURE; SOMNOLENCE; TREATMENT OUTCOME;

ADULT; ANTIMETABOLITES, ANTINEOPLASTIC; CLINICAL TRIALS; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L2; METHOTREXATE;

EID: 0029868007     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050160     Document Type: Review

References (58)

1. Abromowitch M, Ochs J, Pui CH et al. (1988) Efficacy of high-dose methotrexate in childhood acute lymphocytic leukemia: analysis by contemporary risk classifications. Blood 71:866-869
2. Ackland SP, Schilsky RL (1987) High-dose methotrexate. a critical reappraisal. J Clin Oncol 5:2017-2031
3. Amadori S, Annino L, Ferrari A et al. (1994) Therapy of adult acute Iymphoblastic leukemia. Preliminary results of the GIMEMA ALL/0288 study. In: Büchner et al. (eds) Acute leukemias IV, prognostic factors. Springer, Berlin Heidelberg New York, p 432
4. Bernard S, Etienne MC, Fischel JL et al. (1991) Critical factors for the reversal of methotrexate cytotoxicity by folinic acid. Br J Cancer 63:303-307
5. Bernini JC, Fort DW, Griener JC et al. (1995) Aminophylline for methotrexate induced neurotoxicity. Lancet 345:544-547
6. Bleyer W (1990) Acute lymphoblastic leukemia in children. Advances and prospects. Cancer 65:689-695
7. Borsi JD, Moe PJ (1987) Prognostic importance of systemic clearance of methotrexate in childhood ALL. Cancer 60:3020-3024
8. Borsi JD, Wesenberg F, Stokland T et al. (1991) How much is too much? Folinic acid rescue dose in children with acute lymphoblastic leukemia. Eur J Cancer 27:1006-1009
9. Bowman WP, Shuster J, Cook B et al. (1992) Improved survival for children with B cell (SIg +) cell acute lymphoblastic leukemia (B-ALL) and stage IV small non-cleaved cell lymphoma (SNCCL). Proc ASCO 11:277 (abstract)
10. Camitta B, Leventhal B, Lauer S et al. (1989) Intermediatedose intravenous methotrexate and mercaptopurine therapy for non-T, non-B acute lymphocytic leukemia of childhood: a Pediatric Oncology Group study. J Clin Oncol 7:1539-1544
11. Camitta B, Mahoney D, Leventhal B et al. (1994) Intensive intravenous methotrexate and mercaptopurine treatment of higher-risk non-T, non-B acute lymphocytic leukemia. A Pediatric Oncology Group Study. J Clin Oncol 12:1383-1389
12. Ch'ien IT, Aur RJA, Verzosa MS et al . (1981) Progression of methotrexate induced leukoencephalopathy in children with leukemia. Med Pediatr Oncol 9:133-141
13. Chessels JM, Cox TCS, Kendall B et al. (1990) Neutrotoxicity in lymphoblastic leukemia: comparison of oral and intramuscular methotrexate and two doses of radiation. Arch Dis Child 65:416-422
14. Cuttner J, Mick R, Budman DR et al. (1991) Phase III trial of brief intensive treatment of adult acute lymphocytic leukemia comparing daunorubicin and mitoxantrone: a CALGB study. Leukemia 5:425-431
15. Djerassi I (1967) Methotrexate infusions and intensive supportive care in the management of children with acute lymphocytic leukemia: follow-up report. Cancer Res 27:2561
16. Donelli MG, Zucchetti M, Robatto A et al. (1995) Pharmacokinetics of HD-MTX in infants, children, and adolescents with non-B acute lymphoblastic leukemia. Med Pediatr Oncol 24:154-59
17. Durrant IJ, Richards SM (1993) Results of Medical Research Council trial UKALL IX in acute lymphoblastic leukemia in adults: report from the Medical Resarch Council Working Party on adult leukemia. Br J Haematol 85:84-92
18. Elonen E, Almqvist A, Hanninen A et al. (1991) Intensive treatment of acute lymphatic leukemia in adults: ALL86 protocol. Hematologica 76[Suppl 4]:133
19. Evans WE, Crom WR, Abromowitch M et al. (1986) Clinical pharmacodynamics of high-dose methotrexate in acute lymphocytic leukemia. N Engl J Med. 314:471-477
20. Evans WE, Hutson PR, Stewart CF et al. (1983) Methotrexate cerebrospinal fluid and serum concentrations after intermediate-dose methotrexate infusion. Clin Pharmacol Ther 33:301-307
21. Evans WE, Schell MJ, Pui CH (1990) MTX clearance is more important for intermediate-risk ALL. J Clin Oncol 8:1115-1116 (letter)
22. Evensen SA, Brinch L, Tjonnefjord G et al. (1994) Estimated 8-year survival of more than 40% in a population-based study of 79 adult patients with acute lymphoblastic leukemia. Br J Haematol 88:88-93
23. Feickert HJ, Bettoni C, Schrappe M et al. (1993) Event-free survival of children with T-cell acute lymphoblastic leukemia after introduction of high-dose methotrexate in multicenter trial ALL-BFM86. Proc ASCO 12:317
24. Fenaux P, Lai JL, Miaux O et al. (1989) Burkitt cell acute leukemia (L3 ALL) in adults: a report of 18 cases. Br J Haematol 71:371
25. Finnish Leukemia Group (1992) Long-term survival in acute lymphoblastic leukemia in adults: a prospective study of 51 patients. Eur J Haematol 48:75-82
26. Fleming GF, Schilsky RL (1992) Antifolates: the next generation. Semin Oncol 19:707-719
27. Frankel L, Wang Y-M, Shuster J et al. (1984) Effects of early leucovorin rescue. J Clin Oncol 2:1072 (letter)
28. Freeman AI, Wang JJ, Sinks LF (1977) High-dose methotrexate in acute lymphocytic leukemia. Cancer Treat Rep 61:727-731
29. Freeman AI, Weinberg V, Brecher ML et al. (1983) Comparison of intermediate-dose methotrexate with cranial irradiation for the post-induction treatment of acute lymphocytic leukemia in children. N Engl J Med 308:477-484
30. Hann IM, Eden OB, Barnes J et al. (1990) 'MACHO' chemotherapy for stage IV B cell lymphoma and B cell acute lymphoblastic leukemia of childhood. Br J Haematol 76:359-364
31. Hoelzer D (1990) Change in treatment strategies for adult acute lymphoblastic leukemia (ALL) according to prognostic factors and minimal residual disease. Bone Marrow Transplant 6[Suppl 1]:66-70
32. Hoelzer D (1991) High dose chemotherapy in adult acute lymphoblastic leukemia. Semin Hematol 28 [Suppl 4]:84-89
33. Hoelzer D, Ludwig WD, Thiel E et al. (1996) Improved outcome in adult B-cell acute lymphoblastic leukemia. Blood 87 (2): 495-508
34. Holcenberg JS (1984) Effects of early leucovorin rescue. J Clin Oncol 1:1072 (letter)
35. Kamen BA, Vietti T (1989) Letter to the editor. Br J Cancer 60:799
36. Kantarjian H, O'Brien S, Beran M et al. (1995) Update of the hyper-CVAD program in newly diagnosed adult acute lymphocytic leukemia (ALL). Blood 86[S1]:173a
37. Lacerda JF, Goker E, Kheradpour A et al. (1995) Selectivetreatment of SCID mice bearing methotrexate-transport-resistant human acute lymphoblastic leukemia tumors with trimethrexate and leucovorin protection. Blood 85:2675
38. Lauer SJ, Toledano S, Winick N et al. (1995) A comparison of early intensive methotrexate/mercaptopurine (MTX/MP) vs early intensive alternating chemotherapy for high-risk acute lymphoblastic leukemia (HR-ALL). A Pediatric Oncology Group (POG) randomized phase-III study. Proc ASCO 14:342
39. Linker CA, Levitt LJ, O'Donnell M et al. (1991) Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy: a follow-up report. Blood 78:2814-2822
40. Linker CA, Ries CA, Damon LE et al. (1994) Pilot study of intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia. Blood 84:[Suppl 1]559 (abstract)
41. 2 methotrexate. Eur J Cancer 26:492-495
42. Niemeyer CM, Gelber RD, Tarbell NJ et al. (1991) Low-dose versus high-dose methotrexate during remission induction in childhood acute lymphoblastic leukemia (protocol 81-01 update). Blood 78:2514-2529
43. Patte C, Michon J, Frappez D et al. (1994) Therapy of Burkitt and other B-cell acute lymphoblastic leukemia and lymphoma: experience with the LMB protocols of the SFOP (French Paediatric Oncology Society) in children and adults. Baillières Clin Haematol 7:339
44. Pinkel D, Woo S (1994) Prevention and treatment of meningeal leukemia in children. Blood 84:355-366
45. Pui CH, Simone JV, Hancock M et al. (1992) Impact of three methods of treatment intensification on acute lymphoblastic leukemia in children: long-term results of the St. Jude Total Therapy Study X. Leukemia 6:150-157
46. Reiter A, Schrappe M, Ludwig WD et al. (1994) Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood 84:3122-3133
47. Reiter A, Schrappe M, Parwaresch R et al. (1995) Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage - a report of the Berlin-Frankfurt-Münster Group. J Clin Oncol 13:359-372
48. Relling MV, Fairclough D, Ayers D et al. (1994) Patient characteristics associated with high-risk methotrexate concentrations and toxicity. J Clin Oncol 12:1667-1672
49. Riehm H. Gadner H, Henze G et al. (1990) Results and significance of six randomized trials in four consecutive ALLBFM studies. Haematology and Blood Transfusion 33:449
50. Schorin M, Blattner S, Gelber RD et al. (1994) Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber Cancer Institute/Children's Hospital acute lymphoblastic leukemia consortium protocol 85-01. J Clin Oncol 12:740-747
51. Schwenn MR, Blattner SR, Lynch E et al. HiC-COM (1991) A 2-month intensive chemotherapy regimen for children with stage III and IV Burkitt's lymphoma and B-cell acute lymphoblastic leukemia. J Clin Oncol 9:133-138
52. Sirotnak FM , Moccio DM, Dorick DM (1978) Optimization of high-dose methotrexate with leucovorin rescue therapy in the L1210 leukemia and sarcoma 180 murine tumor models. Cancer Res 38:345-353
53. Trueworthy R, Shuster J, Look T et al. (1992) Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: a Pediatric Oncology Group study. J Clin Oncol 10:606-613
54. Wiernik PH, Dutcher JP, Paietta E et al. (1993) Long term follow-up of treatment and potential cure of adult acute lymphocytic leukemia with MOAD: a non-anthracycline containing regimen. Leukemia 7:1236-1241
55. Willemze R, Hijlmans JM, den Ottolander GJ et al. (1995) High-dose Ara-C for remission induction and consolidation of previously untreated adults with ALL or lymphobiastic lymphoma. Ann Hematol 70:71-74
56. Witehead VM, Vuchich MJ, Lauer SJ et al. (1992) Accumulation of high levels of methotrexate polyglutamates in lymphoblasts from children with hyperdiploid (greater than 50 chromosomes) B lineage acute lymphoblastic leukemia: a Pediatric Oncology Group Study. Blood 80:1316
57. Wolfrom C., Fengler R, Hartmann R et al. (1990) Toxicity of high dose mehotrexate infusions with conventional and reduced LV rescue. Klin Padiatr 202:295 (abstract)
58. Wolfrom C, Hartmann R, Fengler R, Henze G (1993) Randomized comparison of 36-hour intermediate-dose versus 4-hour high-dose methotrexate infusions for remission induction in relapsed childhood acute lymphoblastic leukemia. J Clin Oncol 11:827-833